Variable distribution in the whole study population (n=1461) and in subgroups with fibrosis progression rate (FPR) <0.13 or ≥0.13, respectively
| All (n=1461) | FPR<0.13 (n=719) | FPR≥0.13 (n=742) | |
|---|---|---|---|
| Sex | |||
| Female | 530 (36.3%) | 295 (41.0%) | 235 (31.7%) |
| Male | 931 (63.7%) | 424 (59.0%) | 507 (68.3%) |
| Route of infection | |||
| Non-IVDU | 683 (46.7%) | 402 (55.9%) | 281 (37.9%) |
| IVDU | 778 (53.3%) | 317 (44.1%) | 461 (62.1%) |
| HCV genotype | |||
| Non-3 | 1046 (71.6%) | 562 (78.2%) | 484 (65.2%) |
| 3 | 415 (28.4%) | 157 (21.8%) | 258 (34.8%) |
| Diabetes | |||
| Absent | 1338 (91.6%) | 662 (92.1%) | 676 (91.1%) |
| Present | 123 (8.4%) | 57 (7.9%) | 66 (8.9%) |
| Significant alcohol drinking | |||
| Absent* | 840 (57.5%) | 418 (58.1%) | 422 (56.9%) |
| Missing data (imputed as 0.22) | 332 (22.7%) | 179 (24.9%) | 153 (20.6%) |
| Present | 289 (19.8%) | 122 (17.0%) | 167 (22.5%) |
| Anti-HIV | |||
| Absent* | 1129 (77.3%) | 562 (78.2%) | 567 (76.4%) |
| Missing data (imputed as 0.081) | 227 (15.5%) | 114 (15.9%) | 113 (15.2%) |
| Present | 105 (7.2%) | 43 (6.0%) | 62 (8.4%) |
| Age at infection (years) | 20 (9) | 18 (7) | 22 (11) |
| Duration of infection (years) | 21 (13) | 26 (12) | 16 (11) |
| BMI, kg/m2 | 24 (5) | 24 (5) | 24 (5) |
Discrete variables are presented as n (%), continuous variables as median values (IQR).
*Absent was coded as 0 and present as 1.
BMI, body mass index.